The Rapid Development of New Biological Solutions
Chronic respiratory illnesses greatly hinder individuals’ day-to-day activities on a global scale. Among them, Asthma is particularly problematic as it not only limits one’s physical activity, but is also mentally taxing with the ongoing struggle of not being able to breathe due to the narrowing of the airways. As the prevalence continues to increase, the exacerbation of the issue on the burden of the healthcare system continues to increase. Traditional medications/pharmaceuticals fall short in addressing the entirety of the issue for cases of a higher degree of severity. Medical interventions are then required for the exacerbations that occur on a continuous basis. Therefore, it is critical to explore new treatment modalities like Regenerative Medicine Thailand. The frontiers of current interventions are cellular therapies. Incorporating new biological solutions provides the patients who do not respond to traditional therapies with hope. This is what scientists are focusing on with researchers of UC-MSCs.
The Complexity of the Cellular Mechanisms of Airway Restriction
Understanding the underlying mechanisms of this respiratory condition, specifically Asthma, requires an understanding of the cellular mechanisms and the role of the different components of the system. From a medical standpoint, the disease is primarily associated with chronic airway obstruction connected to an over-excessive immune response. Once the respiratory system is exposed to a challenge from the environment, the epithelium of the respiratory system releases alarmin which then stimulate the innate immune response and the T helper 2 cells. This ultimately leads to the secretion of numerous interleukins that will then bring eosinophils to the lung tissue. This environment of inflammation that is chronic will then cause remodeling of the airways which will bring structural changes such as hyperplasia of the goblet cells, and hypertrophy of the smooth muscle and subepithelial fibrosis. Thick airway walls limit the airflow able to pass through airways. The airways’ walls become highly sensitive to minor irritants. The damage suffers from structural degradation, and inflammation suppression proves insufficient for long-term management of this disease, highlighting the need for Regenerative Medicine Thailand using UC-MSCs.
Limitations of Standard Modalities of Treatment and Pharmacotherapy
Treatment of Asthma requires a combination of inhaled corticosteroids and fast-acting beta-agonists. These pharmacological agents relax constricted smooth muscles and inhibit some immune pathways. In advanced phenotypes, additional agents like systemic corticosteroids or some form of monoclonal therapy for targeted mechanism pathways are added. Chronic administration of corticosteroids causes the patient to experience rapid loss of control of the disease with progressive impairment of pulmonary function. The burden of chronic therapy with corticosteroids and the progressive impairment of metabolism, weight gain, and osteoporosis is not offset with the introduction of other monoclonal agents. The chronic administration of corticosteroids impairs structural and functional restoration of lung tissue. It is for the purpose of restoration of structural and functional supportive lung tissues that regenerative medicine and therapy with umbilical cord-derived MSCs warrants further investigation.
Mechanisms of Restoration of Supportive Tissues
Therapies with umbilical cord-derived MSCs (UC-MSCs), unlike other therapies, have the potential to repair damaged tissues. These stem cells have the capability of tissue repair and extensive regenerative properties. Following infusion, they undergo the process of chemotaxis and migrate to areas of inflammation. In the airways of Asthma patients, UC-MSCs can secrete a number of bioactive agents, one of which is prostaglandin E2 and TGF-beta, both of which enhance the process of inflammation resolution. Even with their immunosuppressive capabilities, they can reverse airway remodeling through other mechanisms, which include the secretion of extracellular vesicles. These vesicles, through the activity of matrix metalloproteinases, can clear fibrosis and inhibit the overgrowth of smooth muscle. Because of all of these effects, the normal structure of the airways is restored. These specialized cells can be immune evasive and differentiated compared to conventional medicine. Thus, in these aspects, they can be stated to be supporting the field of Regenerative Medicine Thailand. In addition, they alter the lung environment to prevent further respiratory exacerbations.
Figure 1: Mechanisms of Restoration of Supportive Tissues
Strategic Advancements in Southeast Asian Medical Hubs
The rapid expansion of Southeast Asia’s emerging health systems to accommodate advanced cellular therapies is a transformational element of their development. Transforming regions into biological innovation hubs is a governmental priority. The Regenerative Medicine Thailand infrastructure is rapidly expanding at an unprecedented pace. Thailand has modern biomedical research facilities that are integrated with clinical centers. Thailand offers a unique convergence of top-quality medical expertise, cost-effective research operations, and an emphasis on developing biotechnology. This attracts international collaborations targeting high prevalence diseases in the region, such as Asthma. Local researchers are focused on developing advanced cellular therapies using UC-MSCs within sustained cell culture systems that will retain genetic stability. The tropical climate coupled with specific environmental allergens places the local population in the optimal position to assess the efficacy of modern respiratory therapies.
Final Summary of Biological Therapeutic Frontiers
The overwhelming nature of chronic respiratory diseases makes compelling the complete overhaul of therapeutic options. Asthma presents a clear need for solutions beyond the temporary management of symptoms due to the destructive nature of the illness. Advanced cellular therapies are positioned to be the first effective solution to chronic airway remodeling and inflammation. The ability of UC-MSCs to change the course of several respiratory conditions is promising. While traditional medicines are proven to be inadequate, the advanced Regenerative Medicine Thailand sector will offer the first effective solution to chronic remodeling and inflammation of the airways. Regenerative medicine will improve the quality of patient’s lives.